HK1121698A1 - Marked bovine viral diarrhea virus vaccines - Google Patents

Marked bovine viral diarrhea virus vaccines

Info

Publication number
HK1121698A1
HK1121698A1 HK09101950.7A HK09101950A HK1121698A1 HK 1121698 A1 HK1121698 A1 HK 1121698A1 HK 09101950 A HK09101950 A HK 09101950A HK 1121698 A1 HK1121698 A1 HK 1121698A1
Authority
HK
Hong Kong
Prior art keywords
diarrhea virus
bovine viral
virus vaccines
viral diarrhea
marked
Prior art date
Application number
HK09101950.7A
Other languages
English (en)
Inventor
Chichi Huang
Michael George Sheppard
Xuemei Cao
Gabriele Zybarth
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1121698A1 publication Critical patent/HK1121698A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/18Togaviridae; Flaviviridae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361Methods of inactivation or attenuation
HK09101950.7A 2005-12-07 2009-03-02 Marked bovine viral diarrhea virus vaccines HK1121698A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74831205P 2005-12-07 2005-12-07
PCT/IB2006/003412 WO2007066188A2 (en) 2005-12-07 2006-11-24 Marked bovine viral diarrhea virus vaccines

Publications (1)

Publication Number Publication Date
HK1121698A1 true HK1121698A1 (en) 2009-04-30

Family

ID=38123251

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09101950.7A HK1121698A1 (en) 2005-12-07 2009-03-02 Marked bovine viral diarrhea virus vaccines

Country Status (17)

Country Link
US (2) US20080305130A1 (ko)
EP (1) EP1973565B1 (ko)
JP (1) JP2009519014A (ko)
KR (2) KR101097547B1 (ko)
CN (1) CN101355963B (ko)
AR (1) AR057225A1 (ko)
AU (1) AU2006323028B2 (ko)
BR (1) BRPI0619566A2 (ko)
CA (1) CA2639074C (ko)
HK (1) HK1121698A1 (ko)
NO (1) NO20081909L (ko)
NZ (1) NZ567668A (ko)
RU (1) RU2394594C2 (ko)
TW (1) TW200734463A (ko)
UA (1) UA95619C2 (ko)
WO (1) WO2007066188A2 (ko)
ZA (1) ZA200803558B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130912A1 (en) * 2008-06-04 2009-12-09 Institut für Viruskrankeiten und Immunprophylaxe Pestivirus replicons providing an RNA-based viral vector system
CN102517260A (zh) * 2011-12-29 2012-06-27 中国人民解放军军事医学科学院野战输血研究所 携带牛病毒性腹泻病毒非结构蛋白ns3优势区的融合蛋白及其重组表达方法与应用
MX2015002688A (es) * 2012-08-29 2015-05-12 Intervet Int Bv Vacuna indicadora.
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN103197082B (zh) * 2013-04-16 2015-07-15 深圳出入境检验检疫局动植物检验检疫技术中心 牛病毒性腹泻病毒抗体快速检测试纸条
EA025263B1 (ru) * 2014-06-23 2016-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Пробиотех" Разбавитель-адъювант для сухой живой вакцины против трихофитии крупного рогатого скота
CN110554187B (zh) * 2018-05-30 2022-07-05 内蒙古元山生物科技有限公司 一种用于检测牛病毒性腹泻病毒抗体的表达蛋白、elisa试剂盒及其制备方法和应用
KR102434714B1 (ko) * 2021-02-16 2022-08-23 바디텍메드(주) 중화 항체 및 인터페론-감마 생성 여부를 이용한 능동 면역 진단을 위한 정보 제공 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5709865A (en) 1994-11-10 1998-01-20 Biostar Inc. Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6060457A (en) 1996-06-20 2000-05-09 Universite De Montreal DNA plasmid vaccine for immunization of animals against BVDV
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
JP4864661B2 (ja) * 2006-11-22 2012-02-01 東京エレクトロン株式会社 太陽電池の製造方法及び太陽電池の製造装置
US10790893B2 (en) 2016-09-30 2020-09-29 Guangdong Oppo Mobile Telecommunications Corp., Ltd. Signal transmission method and apparatus

Also Published As

Publication number Publication date
NZ567668A (en) 2011-07-29
US20120021001A1 (en) 2012-01-26
US20080305130A1 (en) 2008-12-11
WO2007066188A3 (en) 2008-06-05
CN101355963B (zh) 2012-03-21
KR101097547B1 (ko) 2011-12-22
BRPI0619566A2 (pt) 2011-10-04
UA95619C2 (ru) 2011-08-25
RU2008120331A (ru) 2010-01-20
NO20081909L (no) 2008-05-21
KR101045165B1 (ko) 2011-06-30
EP1973565B1 (en) 2013-05-15
RU2394594C2 (ru) 2010-07-20
WO2007066188A2 (en) 2007-06-14
ZA200803558B (en) 2009-09-30
AU2006323028A1 (en) 2007-06-14
AR057225A1 (es) 2007-11-21
CA2639074A1 (en) 2007-06-14
KR20110045072A (ko) 2011-05-03
CA2639074C (en) 2013-10-08
JP2009519014A (ja) 2009-05-14
KR20080065696A (ko) 2008-07-14
TW200734463A (en) 2007-09-16
CN101355963A (zh) 2009-01-28
AU2006323028B2 (en) 2010-02-25
EP1973565A2 (en) 2008-10-01

Similar Documents

Publication Publication Date Title
EP1948229A4 (en) COMBINED VACCINE COMPRISING AN ATTENUATED VIRUS OF BOVINE VIRAL DIARRHEA
EP1909829A4 (en) RECOMBINANT GRIP VACCINES
HK1121698A1 (en) Marked bovine viral diarrhea virus vaccines
GB0522476D0 (en) Oncolytic herpes virus vectors
EP1945250A4 (en) RECOMBINANT SUBUNIT VACCINE FOR INFLUENZA VIRUS
GB0526211D0 (en) Viral vectors
GB0513421D0 (en) Vaccines
EP1773403A4 (en) VIRAL ADJUVANZIA
IL192084A0 (en) Vaccine
GB0504436D0 (en) Vaccine
EP1723238A4 (en) MODIFIED ONCOLYTIC VIRUSES
IL189329A0 (en) Vaccination against dengue virus infection
EP1874346A4 (en) RECOMBINANT FLAVIVIRUS VACCINES
HK1123055A1 (en) Hepatitis c virus nucleic acid vaccine
EP1961814A4 (en) RECOMBINANT POLYVALENT VACCINE
EP1856250A4 (en) NEW VACCINES LIVING VIRUSES
EP1871786A4 (en) PEPTIDE VACCINE AGAINST THE GRIPPEVIRUS
HK1109069A1 (en) Vaccine composition against hepatitis c virus
GB0416487D0 (en) Modified virus
GB0524409D0 (en) Vaccines
ZA200709605B (en) HIV vaccine
EP1907537A4 (en) PREPARATIONS BASED ON PARAMYXOVIRIDAE VIRUS
GB0524408D0 (en) Vaccines
GB0515135D0 (en) Vaccine
ZA200802176B (en) Vaccination against dengue virus infection

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161124